Goldman Sachs Group Inc Haemonetics Corp Transaction History

Goldman Sachs Group Inc

$706 Billion
Q2 2025

A detailed history of Goldman Sachs Group Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 644,500 shares of HAE stock, worth $32.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

644,500

Previous 463,481 39.06%

Holding current value

$32.1 Million

Previous $29.5 Million 63.26%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$56.04 - $74.77 $10.1 Million - $13.5 Million	181,019 Added 39.06%	644,500 $48.1 Million
Q1 2025 May 09, 2025	SELL	$59.34 - $80.05 $13.8 Million - $18.6 Million	-231,815 Reduced 33.34%	463,481 $29.5 Million
Q4 2024 Feb 11, 2025	BUY	$71.16 - $93.38 $8.04 Million - $10.6 Million	113,011 Added 19.41%	695,296 $54.3 Million
Q3 2024 Nov 14, 2024	SELL	$72.45 - $91.58 $2.55 Million - $3.22 Million	-35,147 Reduced 5.69%	582,285 $46.8 Million
Q2 2024 Aug 13, 2024	BUY	$81.24 - $97.37 $37.1 Million - $44.4 Million	456,286 Added 283.15%	617,432 $51.1 Million
Q1 2024 May 15, 2024	SELL	$71.24 - $85.35 $2.14 Million - $2.57 Million	-30,107 Reduced 15.74%	161,146 $13.8 Million
Q4 2023 Feb 13, 2024	BUY	$80.59 - $92.61 $1.97 Million - $2.26 Million	24,394 Added 14.62%	191,253 $16.4 Million
Q3 2023 May 14, 2024	SELL	$82.56 - $93.49 $2.01 Million - $2.28 Million	-24,394 Reduced 12.75%	166,859 $14.9 Million
Q3 2023 Nov 14, 2023	SELL	$82.56 - $93.49 $2.39 Million - $2.71 Million	-28,983 Reduced 14.8%	166,859 $14.9 Million
Q2 2023 May 14, 2024	BUY	$80.84 - $89.45 $1.45 Million - $1.6 Million	17,933 Added 10.08%	195,842 $16.7 Million
Q2 2023 Aug 14, 2023	BUY	$80.84 - $89.45 $1.45 Million - $1.6 Million	17,933 Added 10.08%	195,842 $16.7 Million
Q1 2023 May 14, 2024	SELL	$72.75 - $90.6 $5.16 Million - $6.42 Million	-70,894 Reduced 28.49%	177,909 $14.7 Million
Q1 2023 May 11, 2023	SELL	$72.75 - $90.6 $5.16 Million - $6.42 Million	-70,894 Reduced 28.49%	177,909 $14.7 Million
Q4 2022 May 14, 2024	BUY	$73.85 - $86.14 $7.99 Million - $9.32 Million	108,252 Added 77.02%	248,803 $19.6 Million
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $7.99 Million - $9.32 Million	108,252 Added 77.02%	248,803 $19.6 Million
Q3 2022 May 14, 2024	BUY	$63.3 - $78.66 $2.79 Million - $3.46 Million	44,034 Added 45.62%	140,551 $10.4 Million
Q3 2022 Nov 10, 2022	BUY	$63.3 - $78.66 $2.79 Million - $3.46 Million	44,034 Added 45.62%	140,551 $10.4 Million
Q2 2022 May 14, 2024	SELL	$49.27 - $66.08 $4.67 Million - $6.26 Million	-94,736 Reduced 49.53%	96,517 $6.29 Million
Q2 2022 Aug 15, 2022	SELL	$49.27 - $66.08 $1.48 Million - $1.99 Million	-30,113 Reduced 23.78%	96,517 $6.29 Million
Q1 2022 May 16, 2022	BUY	$43.77 - $63.22 $442,558 - $639,217	10,111 Added 8.68%	126,630 $8.01 Million
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $658,866 - $991,823	13,297 Added 12.88%	116,519 $6.18 Million
Q3 2021 Nov 10, 2021	BUY	$57.6 - $70.59 $5.95 Million - $7.29 Million	103,222 New	103,222 $7.29 Million

Others Institutions Holding HAE

# of Institutions

337

Shares Held

53.6M

Call Options Held

540K

Put Options Held

306K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.55B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Haemonetics Corp Transaction History